RHP(RHP)
RHP
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.84B | $3.05B | $3.16B |
| Low | $2.80B | $2.91B | $3.16B |
| High | $2.92B | $3.39B | $3.16B |
| EBITDA Avg | $1.19B | $1.28B | $1.33B |
| Low | $1.18B | $1.22B | $1.32B |
| High | $1.23B | $1.42B | $1.33B |
| EBIT Avg | $1.14B | $1.23B | $1.27B |
| Low | $1.13B | $1.17B | $1.27B |
| High | $1.17B | $1.36B | $1.27B |
| Net Income Avg | $278M | $328M | $367M |
| Low | $275M | $314M | $316M |
| High | $281M | $343M | $401M |
| EPS Avg | $4.22 | $4.92 | $5.43 |
| Low | $4.18 | $4.76 | $4.79 |
| High | $4.25 | $5.20 | $6.08 |
| Analysts (Rev / EPS) | 5 / 2 | 6 / 3 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $631M | $810M | $713M | $794M | $669M | $830M |
| Low | $622M | $782M | $699M | $778M | $656M | $813M |
| High | $644M | $885M | $742M | $826M | $696M | $863M |
| EBITDA Avg | $265M | $340M | $299M | $333M | $281M | $348M |
| Low | $261M | $328M | $293M | $327M | $275M | $342M |
| High | $270M | $372M | $311M | $347M | $292M | $363M |
| EBIT Avg | $253M | $325M | $286M | $319M | $269M | $333M |
| Low | $250M | $314M | $280M | $312M | $263M | $326M |
| High | $258M | $355M | $298M | $331M | $279M | $347M |
| Net Income Avg | $33M | $89M | $82M | $109M | $42M | $90M |
| Low | $32M | $87M | $80M | $106M | $41M | $88M |
| High | $35M | $93M | $87M | $114M | $44M | $95M |
| EPS Avg | $0.49 | $1.31 | $1.21 | $1.59 | $0.61 | $1.33 |
| Low | $0.46 | $1.28 | $1.18 | $1.55 | $0.60 | $1.29 |
| High | $0.51 | $1.36 | $1.27 | $1.68 | $0.65 | $1.40 |
| Analysts (Rev / EPS) | 7 / 2 | 5 / 2 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 |